project id: TCGA-LUSC; case submitter id: TCGA-NK-A7XE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 66; days to birth: -24319; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1947; age at diagnosis: 24319; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 13.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 4.383561643835616; pack years smoked: 80.0; is ffpe: false; composition: Not Reported; days to collection: 50; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-NK-A7XE-01A-12; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;